Dominic Schmidt
InvestorGeneral Partner at Advent Life Sciences
London
Writes $25K – $5M checks · typically $1M
About
Dominic Schmidt joined Advent Life Sciences in April 2022, with a background in biochemistry, genomics, molecular oncology, strategy consulting, and life science venture capital. He previously spent eight years as a Partner on the investment team at Syncona, a publicly listed healthcare investment company, where he helped found and grow several life science businesses. He holds a Diplom in Biochemistry from the Free University of Berlin and the Max Planck Institute for Molecular Genetics, and a PhD in Oncology from the University of Cambridge.
Invests in
BiotechLongevity
Experience
- Advent Life SciencesGeneral Partnercurrent2022 — presentLondon, England, United Kingdom
- Glycomine Inc.Non Executive Directorcurrent2024 — presentUnited States
- Beacon TherapeuticsBoard Observercurrent2024 — present
- Pheno Therapeutics LtdNon Executive Directorcurrent2024 — presentEdinburgh, Scotland, United Kingdom
- AviadoBioNon Executive Directorcurrent2022 — presentLondon, England, United Kingdom
- Amphista Therapeutics LimitedNon Executive Directorcurrent2022 — presentCambridge, England, United Kingdom
- Purespring TherapeuticsNon Executive Director2020 — 2022
- Forcefield TherapeuticsNon Executive Director2020 — 2022
- Anaveon AGNon Executive Director2019 — 2022Switzerland
- Syncona LimitedPartner2016 — 2022London, United Kingdom
- Syncona LimitedPartner2014 — 2016London, United Kingdom
- GYROSCOPE Therapeutics LtdNon Executive Director and Board Observer2019 — 2022
- Orbit Biomedical, Inc.Non Executive Director2018 — 2021London / Philadelphia
- Freeline Therapeutics LimitedBoard Observer2015 — 2020London
- L.E.K. ConsultingAssociate2012 — 2014
- Cancer Research UKDoctoral Student2007 — 2011
- Max Planck Institute for Molecular GeneticsMaster Student and Research Assistant2006 — 2007
Education
- University of CambridgeDoctor of Philosophy (Ph.D.), Oncology2007 — 2011
- Freie Universität BerlinGerman Diplom Degree / M.Sc., Biochemistry2002 — 2007
Skills & more
+10 more
StrategyBioinformaticsBusiness StrategyCell BiologyGeneticsData AnalysisLife SciencesStrategy ConsultingVenture CapitalFinancial ModelingLanguages English · German
From Dominic's professional profile.
Same school
Also attended University of Cambridge621
+ 615 more
Also attended Freie Universität Berlin51
+ 45 more
Shared employers
Also worked at Amphista Therapeutics Limited3
Also worked at Syncona Limited4
Also worked at L.E.K. Consulting117
+ 111 more
Also worked at Cancer Research UK18
+ 12 more
Investments
Board seats
Amphista TherapeuticsAviadoBioBeacon TherapeuticsGlycomineGyroscope TherapeuticsOrbit BiomedicalPheno Therapeutics
Per the firm's website.
Colleagues at Advent Life Sciences
Network5
Investors connected to Dominic in public investor directories — a warm-intro map.

.png)
















.jpg)



















